Methods and kits for diagnosing schizophrenia,

D. Offen; R. Barzilay; E. Levanon; K. Khermesh-Shostak

Methods and kits for diagnosing schizophrenia,

D. Offen (Inventor), R. Barzilay (Inventor), E. Levanon (Inventor), K. Khermesh-Shostak (Inventor)

The Mina and Everard Goodman Faculty of Life Sciences

Research output: Patent

Abstract

Methods and kits for diagnosing schizophrenia are disclosed. The diagnostic method comprises analyzing in a biological sample of a subject a level of A-to-I RNA editing of at least one CNS-expressed gene as set forth in Table 1, wherein an amount of the A-to-I RNA editing of the at least one gene below a predetermined level is indicative of schizophrenia in the subject.

Original language	English
Patent number	US20150284793A1
State	Published - 2015

Cite this

@misc{7619d33edc6c40e4ba06a1ac98f266cd,

title = "Methods and kits for diagnosing schizophrenia,",

abstract = "Methods and kits for diagnosing schizophrenia are disclosed. The diagnostic method comprises analyzing in a biological sample of a subject a level of A-to-I RNA editing of at least one CNS-expressed gene as set forth in Table 1, wherein an amount of the A-to-I RNA editing of the at least one gene below a predetermined level is indicative of schizophrenia in the subject.",

author = "D. Offen and R. Barzilay and E. Levanon and K. Khermesh-Shostak",

year = "2015",

language = "אנגלית",

type = "Patent",

note = "US20150284793A1",

}

TY - PAT

T1 - Methods and kits for diagnosing schizophrenia,

AU - Offen, D.

AU - Barzilay, R.

AU - Levanon, E.

AU - Khermesh-Shostak, K.

PY - 2015

Y1 - 2015

N2 - Methods and kits for diagnosing schizophrenia are disclosed. The diagnostic method comprises analyzing in a biological sample of a subject a level of A-to-I RNA editing of at least one CNS-expressed gene as set forth in Table 1, wherein an amount of the A-to-I RNA editing of the at least one gene below a predetermined level is indicative of schizophrenia in the subject.

AB - Methods and kits for diagnosing schizophrenia are disclosed. The diagnostic method comprises analyzing in a biological sample of a subject a level of A-to-I RNA editing of at least one CNS-expressed gene as set forth in Table 1, wherein an amount of the A-to-I RNA editing of the at least one gene below a predetermined level is indicative of schizophrenia in the subject.

UR - https://patents.google.com/patent/US20150284793A1/en

M3 - ???researchoutput.researchoutputtypes.patent.patent???

M1 - US20150284793A1

ER -

Methods and kits for diagnosing schizophrenia,

Abstract

Other files and links

Fingerprint

Cite this